Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Inclusion Criteria:

• Male or female subjects > or equal to 18 years of age.

• Presence of candidemia (positive blood culture) or invasive candidiasis (histopathologic or cytopathologic examination of a needle aspiration or biopsyspecimen from a normally sterile site excluding mucous membranes showing yeast cells)obtained within the prior 96 hours of the screening visit.

• Subjects who received no more than one prior dose of an echinocandin or polyene.

Exclusion Criteria:

• Subjects with hypersensitivity to anidulafungin, other echinocandins or azoles.

• Presence of confirmed or suspected Candida osteomyelitis, endocarditis or meningitis.

• Subjects with infected prosthetic devices which cannot be removed within 24 hours